In Brief
- Low arginine levels impair immune recognition of cancer cells and viruses.
- Arginine supplementation reduces colon tumors and improves recovery from viral infections in mice.
- Administering arginine after influenza infection helps mice recover faster.
- Findings highlight the amino acid's significant therapeutic potential in treating cancer and viral diseases.
Arginine's Role in Immune System Function
Scientists at Rockefeller University have identified a key role for the amino acid arginine in enhancing immune system responses to cancer and viral infections. According to the study published on November 15, 2026, low levels of arginine disrupt immune cells' ability to recognize and attack dangerous cells, such as tumor cells or infected cells.
Laboratory Findings in Mice
In experimental studies, increasing arginine intake in mice led to a notable reduction in colon cancer tumor growth. Additionally, mice receiving supplemental arginine showed improved outcomes when fighting viral infections. Remarkably, administering arginine after mice contracted influenza accelerated their recovery, highlighting the amino acid's therapeutic potential.
Implications for Treatment
These findings suggest that arginine supplementation could become a straightforward strategy to strengthen immune defenses against cancer and viral diseases. While the results remain preliminary and are based on animal models, they open promising avenues for future research to explore arginine's benefits in human clinical settings.